Likelihood of Approval and Phase Transition Success Rate Model - fitusiran (Hemophilia B (Factor IX Deficiency))

Simple item page
dc.contributor.authorGlobalData
dc.date.accessioned2025-05-01T16:04:24Z
dc.date.available2025-05-01T16:04:24Z
dc.date.issued2023-05-31
dc.identifier.doihttps://doi.org/10.7939/r3-5yd7-kr73
dc.language.isoen
dc.rights© GlobalData Plc. All Rights Reserved. Use of this product is restricted to current faculty, staff, and students of the University. It is the responsibility of each user to ensure that he or she uses this product for individual, non-commercial educational or research purposes only, and does not systematically download or retain substantial portions of information. Users may not reproduce or redistribute unprocessed/raw data portions of the data to any third party, or otherwise engage in the systematic retransmission or commercialization of the data.
dc.subjectHemophilia B
dc.subjectFactor IX deficiency
dc.subjectFitusiran
dc.titleLikelihood of Approval and Phase Transition Success Rate Model - fitusiran (Hemophilia B (Factor IX Deficiency))
dc.typehttp://purl.org/coar/resource_type/c_93fc
ual.jupiterAccesshttp://terms.library.ualberta.ca/authenticated

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Likelihood of Approval and Phase Transition Success Rate Model – Fitusiran in Hemophilia B (Factor IX Deficiency).xlsx
Size:
5.32 MB
Format:
Microsoft Excel XML
Download

Collections

Licenced Monographs